Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent

Skye C. Mayo, Hari Nathan, John L. Cameron, Kelly Olino, Barish H. Edil, Joseph M. Herman, Kenzo Hirose, Richard D. Schulick, Michael A. Choti, Christopher L. Wolfgang, Timothy M. Pawlik

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

BACKGROUND: Prognosis after surgery for pancreatic ductal adenocarcinoma (PDAC) is typically reported from the date of surgery. Survival estimates, however, are dynamic and may change based on the time already survived. The authors sought to assess conditional survival among a large cohort of patients who underwent resection of PDAC. METHODS: Between 1970 and 2008, 1822 patients who underwent resection for PDAC with curative intent were identified. Kaplan-Meier and Cox regression analyses were performed to validate established predictors of survival, and results were compared with 2-year conditional survival. RESULTS: Actuarial survival was 18% at 5 years, with a median survival of 18 months. Multivariate analysis revealed that tumor size, lymph node ratio, and positive margins were associated with worse survival (all P <.001). Differences in actuarial versus conditional survival estimates were greater the more years already survived by the patient. The 2-year conditional survival at 3 years-the probability of surviving to postoperative year 5 given that the patient had already survived 3 years-was 66% versus a 5-year actuarial survival calculated from the time of surgery of 18%. Stratification of 2-year conditional survival by lymph node ratio and margin status revealed that patients with high lymph node ratio or positive margins saw the greatest increase in 2-year conditional survival as more time elapsed (both P ≤.01). CONCLUSIONS: Differences in actuarial versus conditional survival estimates were more pronounced based on the additional years already survived by the patient. Conditional survival may be a helpful tool in counseling patients with PDAC, as it is a more accurate assessment of future survival for those patients who have already survived a certain amount of time. Cancer 2011.

Original languageEnglish (US)
Pages (from-to)2674-2681
Number of pages8
JournalCancer
Volume118
Issue number10
DOIs
StatePublished - May 15 2012
Externally publishedYes

Fingerprint

Adenocarcinoma
Survival
Lymph Nodes
Counseling
Neoplasms
Multivariate Analysis
Regression Analysis

Keywords

  • conditional survival
  • pancreatic cancer
  • surgery
  • Whipple

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Mayo, S. C., Nathan, H., Cameron, J. L., Olino, K., Edil, B. H., Herman, J. M., ... Pawlik, T. M. (2012). Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent. Cancer, 118(10), 2674-2681. https://doi.org/10.1002/cncr.26553

Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent. / Mayo, Skye C.; Nathan, Hari; Cameron, John L.; Olino, Kelly; Edil, Barish H.; Herman, Joseph M.; Hirose, Kenzo; Schulick, Richard D.; Choti, Michael A.; Wolfgang, Christopher L.; Pawlik, Timothy M.

In: Cancer, Vol. 118, No. 10, 15.05.2012, p. 2674-2681.

Research output: Contribution to journalArticle

Mayo, SC, Nathan, H, Cameron, JL, Olino, K, Edil, BH, Herman, JM, Hirose, K, Schulick, RD, Choti, MA, Wolfgang, CL & Pawlik, TM 2012, 'Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent', Cancer, vol. 118, no. 10, pp. 2674-2681. https://doi.org/10.1002/cncr.26553
Mayo SC, Nathan H, Cameron JL, Olino K, Edil BH, Herman JM et al. Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent. Cancer. 2012 May 15;118(10):2674-2681. https://doi.org/10.1002/cncr.26553
Mayo, Skye C. ; Nathan, Hari ; Cameron, John L. ; Olino, Kelly ; Edil, Barish H. ; Herman, Joseph M. ; Hirose, Kenzo ; Schulick, Richard D. ; Choti, Michael A. ; Wolfgang, Christopher L. ; Pawlik, Timothy M. / Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent. In: Cancer. 2012 ; Vol. 118, No. 10. pp. 2674-2681.
@article{1e844b5085654e1e83b61ad8cb37973d,
title = "Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent",
abstract = "BACKGROUND: Prognosis after surgery for pancreatic ductal adenocarcinoma (PDAC) is typically reported from the date of surgery. Survival estimates, however, are dynamic and may change based on the time already survived. The authors sought to assess conditional survival among a large cohort of patients who underwent resection of PDAC. METHODS: Between 1970 and 2008, 1822 patients who underwent resection for PDAC with curative intent were identified. Kaplan-Meier and Cox regression analyses were performed to validate established predictors of survival, and results were compared with 2-year conditional survival. RESULTS: Actuarial survival was 18{\%} at 5 years, with a median survival of 18 months. Multivariate analysis revealed that tumor size, lymph node ratio, and positive margins were associated with worse survival (all P <.001). Differences in actuarial versus conditional survival estimates were greater the more years already survived by the patient. The 2-year conditional survival at 3 years-the probability of surviving to postoperative year 5 given that the patient had already survived 3 years-was 66{\%} versus a 5-year actuarial survival calculated from the time of surgery of 18{\%}. Stratification of 2-year conditional survival by lymph node ratio and margin status revealed that patients with high lymph node ratio or positive margins saw the greatest increase in 2-year conditional survival as more time elapsed (both P ≤.01). CONCLUSIONS: Differences in actuarial versus conditional survival estimates were more pronounced based on the additional years already survived by the patient. Conditional survival may be a helpful tool in counseling patients with PDAC, as it is a more accurate assessment of future survival for those patients who have already survived a certain amount of time. Cancer 2011.",
keywords = "conditional survival, pancreatic cancer, surgery, Whipple",
author = "Mayo, {Skye C.} and Hari Nathan and Cameron, {John L.} and Kelly Olino and Edil, {Barish H.} and Herman, {Joseph M.} and Kenzo Hirose and Schulick, {Richard D.} and Choti, {Michael A.} and Wolfgang, {Christopher L.} and Pawlik, {Timothy M.}",
year = "2012",
month = "5",
day = "15",
doi = "10.1002/cncr.26553",
language = "English (US)",
volume = "118",
pages = "2674--2681",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "10",

}

TY - JOUR

T1 - Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent

AU - Mayo, Skye C.

AU - Nathan, Hari

AU - Cameron, John L.

AU - Olino, Kelly

AU - Edil, Barish H.

AU - Herman, Joseph M.

AU - Hirose, Kenzo

AU - Schulick, Richard D.

AU - Choti, Michael A.

AU - Wolfgang, Christopher L.

AU - Pawlik, Timothy M.

PY - 2012/5/15

Y1 - 2012/5/15

N2 - BACKGROUND: Prognosis after surgery for pancreatic ductal adenocarcinoma (PDAC) is typically reported from the date of surgery. Survival estimates, however, are dynamic and may change based on the time already survived. The authors sought to assess conditional survival among a large cohort of patients who underwent resection of PDAC. METHODS: Between 1970 and 2008, 1822 patients who underwent resection for PDAC with curative intent were identified. Kaplan-Meier and Cox regression analyses were performed to validate established predictors of survival, and results were compared with 2-year conditional survival. RESULTS: Actuarial survival was 18% at 5 years, with a median survival of 18 months. Multivariate analysis revealed that tumor size, lymph node ratio, and positive margins were associated with worse survival (all P <.001). Differences in actuarial versus conditional survival estimates were greater the more years already survived by the patient. The 2-year conditional survival at 3 years-the probability of surviving to postoperative year 5 given that the patient had already survived 3 years-was 66% versus a 5-year actuarial survival calculated from the time of surgery of 18%. Stratification of 2-year conditional survival by lymph node ratio and margin status revealed that patients with high lymph node ratio or positive margins saw the greatest increase in 2-year conditional survival as more time elapsed (both P ≤.01). CONCLUSIONS: Differences in actuarial versus conditional survival estimates were more pronounced based on the additional years already survived by the patient. Conditional survival may be a helpful tool in counseling patients with PDAC, as it is a more accurate assessment of future survival for those patients who have already survived a certain amount of time. Cancer 2011.

AB - BACKGROUND: Prognosis after surgery for pancreatic ductal adenocarcinoma (PDAC) is typically reported from the date of surgery. Survival estimates, however, are dynamic and may change based on the time already survived. The authors sought to assess conditional survival among a large cohort of patients who underwent resection of PDAC. METHODS: Between 1970 and 2008, 1822 patients who underwent resection for PDAC with curative intent were identified. Kaplan-Meier and Cox regression analyses were performed to validate established predictors of survival, and results were compared with 2-year conditional survival. RESULTS: Actuarial survival was 18% at 5 years, with a median survival of 18 months. Multivariate analysis revealed that tumor size, lymph node ratio, and positive margins were associated with worse survival (all P <.001). Differences in actuarial versus conditional survival estimates were greater the more years already survived by the patient. The 2-year conditional survival at 3 years-the probability of surviving to postoperative year 5 given that the patient had already survived 3 years-was 66% versus a 5-year actuarial survival calculated from the time of surgery of 18%. Stratification of 2-year conditional survival by lymph node ratio and margin status revealed that patients with high lymph node ratio or positive margins saw the greatest increase in 2-year conditional survival as more time elapsed (both P ≤.01). CONCLUSIONS: Differences in actuarial versus conditional survival estimates were more pronounced based on the additional years already survived by the patient. Conditional survival may be a helpful tool in counseling patients with PDAC, as it is a more accurate assessment of future survival for those patients who have already survived a certain amount of time. Cancer 2011.

KW - conditional survival

KW - pancreatic cancer

KW - surgery

KW - Whipple

UR - http://www.scopus.com/inward/record.url?scp=84860671112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860671112&partnerID=8YFLogxK

U2 - 10.1002/cncr.26553

DO - 10.1002/cncr.26553

M3 - Article

C2 - 21935914

AN - SCOPUS:84860671112

VL - 118

SP - 2674

EP - 2681

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 10

ER -